Tabula Rasa HealthCare Appoints Kevin Boesen as Chief Sales Officer
MOORESTOWN, N.J., Dec. 19, 2018 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC), a healthcare technology company advancing […]
Equillium Granted U.S. FDA Fast Track Designation for EQ001 for the Treatment of Acute Graft-Versus-Host Disease
Company plans to initiate Phase 1b/2 EQUATE clinical trial in early 2019 LA JOLLA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) […]
Evolus Added to NASDAQ Biotechnology Index
IRVINE, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) — Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced […]
Sify Technologies and GMO GlobalSign to jointly offer SSL/ TLS Certificates in the SAARC region
GlobalSign SSL/TLS certificates are being offered by Safescrypt, the data security business of Sify across India and other SAARC countries […]
Callitas Health, Inc. Releases End-of-Year Update Letter to Shareholders
CINCINNATI, OH, Dec. 19, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Callitas Health Inc. (CSE: LILY, OTCBB: MPHMF, FWB: T3F3), today announced […]
Green Thumb Industries (GTI) Awarded Four Additional Retail Licenses in Pennsylvania with Ability to Open Up to 12 New Stores
GTI’s Retail Footprint Increases to 73 Stores in Nine States CHICAGO and VANCOUVER, British Columbia, Dec. 19, 2018 (GLOBE NEWSWIRE) […]
Pacific Mercantile Bank Provides $5 Million in Financing to Edition Logistics Management
COSTA MESA, Calif., Dec. 19, 2018 (GLOBE NEWSWIRE) — Pacific Mercantile Bank (“the Bank”), the wholly owned subsidiary of Pacific […]
Nemaura to Host Investor Webinar on December 21 to Provide Update on Recent Developments
LOUGHBOROUGH, England – Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible Continuous […]
AMAG Pharmaceuticals to Present at the 37th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Dec. 19, 2018 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William Heiden, president and […]
Savara Announces Interim Results for OPTIMA Clinical Study of Molgradex for the Treatment of NTM
AUSTIN, Texas, Dec. 19, 2018 (GLOBE NEWSWIRE) — Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced interim […]
